Current status of hyperthermic limb perfusion for in-transit melanoma

By I. Ross Merrick  

International Journal of Hyperthermia, Vol. 24, Iss. 3, 2008-01 ,pp. : 205-217

Informa Healthcare

Access to resources Recommend Favorite

Factors Predicting the Risk of In-Transit Recurrence After Sentinel Lymphonodectomy in Patients With Cutaneous Malignant Melanoma

By Kretschmer Lutz   Beckmann Iris   Thoms Kai-Martin   Mitteldorf Christina   Bertsch Hans   Neumann Christine  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1105-1112

Springer Publishing Company

Access to resources Recommend Favorite

Long-term follow-up of 163 consecutive patients treated with isolated limb perfusion for in-transit metastases of malignant melanoma

By Olofsson Roger   Mattsson Jan   Lindnér Per  

International Journal of Hyperthermia, Vol. 29, Iss. 6, 2013-09 ,pp. : 551-557

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

By Rossi Carlo  

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3000-3007

Springer Publishing Company

Access to resources Recommend Favorite

Melan-A specific CD8+ T lymphocytes after hyperthermic isolated limb perfusion: A pilot study in patients with in-transit metastases of malignant melanoma

By Olofsson Roger  

International Journal of Hyperthermia, Vol. 29, Iss. 3, 2013-05 ,pp. : 234-238

Informa Healthcare

Access to resources Recommend Favorite